Breakpoints

106 Episodes

1. #46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

   Published: 10/22/2021
2. #45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

   Published: 9/24/2021
3. #44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

   Published: 9/17/2021
4. #43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

   Published: 8/27/2021
5. #42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring

   Published: 8/20/2021
6. #41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts

   Published: 7/16/2021
7. #40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship

   Published: 6/18/2021
8. #39 – A Little More on the Littles: What Adults Should Know about ID Pediatrics

   Published: 5/21/2021
9. #38 – You're KID-ding! Myths in ID Pediatrics

   Published: 4/23/2021
10. #37 – A Gab about Cab: The Short on Long-Acting Antiretrovirals for HIV

    Published: 4/16/2021
11. #36 – Monoclonal Antibodies: Gateway Drugs for Future Care Delivery Models

    Published: 3/26/2021
12. #35 – Oral Beta-Lactams, Are We Serious?

    Published: 3/19/2021
13. #34 – The New Scoop on Poop: Updates in the Management of C. difficile infections

    Published: 2/19/2021
14. #33 – A Lung Time Coming: Controversies in Community Acquired Pneumonia

    Published: 1/15/2021
15. #32 – Unsolicited Advice: An Honest Discussion of Burnout in Stewardship

    Published: 12/18/2020
16. #31 – “Mind the Gap”: Antimicrobial Stewardship at Transitions of Care

    Published: 11/20/2020
17. #30 – Is More Better? The Role of Combination Therapy for MRSA

    Published: 10/9/2020
18. #29 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2

    Published: 9/11/2020
19. #28 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1

    Published: 9/4/2020
20. #27 – Expert Updates in Gram Negative Resistance: Q&A Session

    Published: 7/31/2020